UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline

Journal of clinical oncology, 2020-06, Vol.38 (17), p.1963-1996

2020

Volltextzugriff (PDF)

MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

Journal of clinical oncology, 2016-03, Vol.34 (7), p.721-730

2016

Volltextzugriff (PDF)

Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3338-3345

2009

Volltextzugriff (PDF)

Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care

Journal of clinical oncology, 2006-02, Vol.24 (6), p.848-855

2006

Volltextzugriff (PDF)

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1594-1600

2012

Volltextzugriff (PDF)

Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3557-3564

2013

Volltextzugriff (PDF)

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1569-1579

2020

Volltextzugriff (PDF)

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

Journal of clinical oncology, 2021-03, Vol.39 (9), p.1001-1009

2021

Volltextzugriff (PDF)

Modeling genetic testing (GT) attitudes in a socio-demographically diverse cohort of patients (pts) with cancer: The importance of race/ethnicity and medical mistrust (MM)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10562-10562

2023

Volltextzugriff (PDF)

Characterizing medical mistrust (MM) in a socio-demographically diverse sample of patients with cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10551-10551

2023

Volltextzugriff (PDF)

Association of TGF-β expression with intratumoral infiltration of cytotoxic T lymphocytes in patients with microsatellite-stable colorectal cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3577-3577

2019

Volltextzugriff (PDF)

Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.12118-12118

2024

Volltextzugriff (PDF)

Outcomes of Helicobacter pylori (HP) infection in esophageal cancer (EC): A 5-year nationwide analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16079-e16079

2023

Volltextzugriff (PDF)

Comparison of clinical characteristics and survival of metastatic breast cancer patients in United States according to insurance status as compared to outcomes in Canada

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18617-e18617

2018

Volltextzugriff (PDF)

RICTOR amplification as a novel therapeutic target for lung cancer brain metastases

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3597-3597

2020

Volltextzugriff (PDF)

Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?

Journal of clinical oncology, 2011-02, Vol.29 (6), p.603-606

2011

Volltextzugriff (PDF)

Tumor infiltrating lymphocytes (TILs) in HER2 positive breast cancer: Evaluation according to the new recommendations by the international TILs working group 2014

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1037-1037

2015

Volltextzugriff (PDF)

Effect of tumor infiltrating lymphocytes (TILs) and stromal CD68 on trastuzumab (T) benefit in early stage HER2 positive breast cancer (BC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.556-556

2015

Volltextzugriff (PDF)

FoundationOne as a relevant tool for comprehensive genomic profiling and assessment of tumor mutation burden in the era of precision oncology in India

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e23096-e23096

2017

Volltextzugriff (PDF)

Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving postprostatectomy IMRT

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.242-242

2015

Volltextzugriff (PDF)

Impact of palliative care consults on racial disparity in do-not resuscitation (DNR) orders at an urban safety net hospital

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10027-10027

2018

Volltextzugriff (PDF)

Distinct dominant T-cell receptors with a tissue resident memory phenotype in individual melanoma metastases

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.3-3

2017

Volltextzugriff (PDF)

Impact of the 21-gene Recurrence Score assay on the adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes in an academic centre in Ontario

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e12026-e12026

2016

Volltextzugriff (PDF)

Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.11512-11512

2018

Volltextzugriff (PDF)

Effect of EGFR mutations on outcomes in NSCLC with brain metastases

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20644-e20644

2016

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(75)

Sprache

Englisch
(75)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Oncology
(17)
Science & Technology
(17)
Humans
(15)
Female
(13)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Middle Aged
(9)
Adult
(7)
Aged
(7)
Male
(7)
Aged, 80 And Over
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Breast Neoplasms - Drug Therapy
(5)
Breast Neoplasms - Pathology
(5)
Pharmacology. Drug Treatments
(5)
Antineoplastic Agents
(4)
Chemotherapy
(4)
Follow-Up Studies
(4)
Neoplasm Staging
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(75)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(75)
NUS Single-Journal Subscriptions
(75)
IngentaConnect Journals
(23)
Ingenta
(23)
MEDLINE
(15)

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline

MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression

Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors

Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin

Modeling genetic testing (GT) attitudes in a socio-demographically diverse cohort of patients (pts) with cancer: The importance of race/ethnicity and medical mistrust (MM)

Characterizing medical mistrust (MM) in a socio-demographically diverse sample of patients with cancer

Association of TGF-β expression with intratumoral infiltration of cytotoxic T lymphocytes in patients with microsatellite-stable colorectal cancer

Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies

Outcomes of Helicobacter pylori (HP) infection in esophageal cancer (EC): A 5-year nationwide analysis

Comparison of clinical characteristics and survival of metastatic breast cancer patients in United States according to insurance status as compared to outcomes in Canada

RICTOR amplification as a novel therapeutic target for lung cancer brain metastases

Bevacizumab and heart failure risk in patients with breast cancer: a thorn in the side?

Tumor infiltrating lymphocytes (TILs) in HER2 positive breast cancer: Evaluation according to the new recommendations by the international TILs working group 2014

Effect of tumor infiltrating lymphocytes (TILs) and stromal CD68 on trastuzumab (T) benefit in early stage HER2 positive breast cancer (BC)

FoundationOne as a relevant tool for comprehensive genomic profiling and assessment of tumor mutation burden in the era of precision oncology in India

Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving postprostatectomy IMRT

Impact of palliative care consults on racial disparity in do-not resuscitation (DNR) orders at an urban safety net hospital

Distinct dominant T-cell receptors with a tissue resident memory phenotype in individual melanoma metastases

Impact of the 21-gene Recurrence Score assay on the adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes in an academic centre in Ontario

Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled cross-over study

Effect of EGFR mutations on outcomes in NSCLC with brain metastases

Aktive Filter

Suchergebnisse filtern